Android Apple

SELLAS announces data indicating key predictor of response to SLS009 in solid cancers

By Yahoo! Finance   |   3 weeks ago
SELLAS announces data indicating key predictor of response to SLS009 in solid cancers

SELLAS Life Sciences Group released positive preclinical data revealing ASXL1 mutation as a key predictor for SLS009 response in solid cancers. These findings validate the potential of ASXL1 mutations as a biomarker for targeted therapy in solid tumors.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.